Published in Epidemiology on March 01, 2011
STAT: Standard Therapy Plus Active Therapy (STAT) | NCT04368117
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol (2014) 5.80
Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial. Trials (2012) 0.84
Dealing with missing data in the Center for Epidemiologic Studies Depression self-report scale: a study based on the French E3N cohort. BMC Med Res Methodol (2013) 0.79
Evaluation of a weighting approach for performing sensitivity analysis after multiple imputation. BMC Med Res Methodol (2015) 0.77
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA (2010) 5.04
Low-flow, low-gradient severe aortic stenosis despite normal ejection fraction is associated with severe left ventricular dysfunction as assessed by speckle-tracking echocardiography: a multicenter study. Circ Cardiovasc Imaging (2011) 2.58
Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch Intern Med (2009) 2.07
Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry. Eur J Heart Fail (2010) 2.04
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. J Natl Cancer Inst (2013) 1.90
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. Eur J Cancer (2011) 1.85
Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J (2007) 1.82
Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J (2010) 1.82
Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. Arch Cardiovasc Dis (2010) 1.75
Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J (2003) 1.71
Continual reassessment method for ordered groups. Biometrics (2003) 1.60
Surgical treatment of active aortic endocarditis: homografts are not the cornerstone of outcome. Ann Thorac Surg (2007) 1.53
Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-alpha release in patients with severe peritonitis: role of tumor necrosis factor-alpha converting enzyme cleavage. Crit Care Med (2005) 1.51
Breast cancer risk in relation to abortion: Results from the EPIC study. Int J Cancer (2006) 1.51
Non-parametric optimal design in dose finding studies. Biostatistics (2002) 1.51
Leukocyte activation: the link between inflammation and coagulation during heatstroke. A study of patients during the 2003 heat wave in Paris. Crit Care Med (2008) 1.50
Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities? J Clin Oncol (2011) 1.48
Long-term outcomes after repaired acute type A aortic dissections. Interact Cardiovasc Thorac Surg (2006) 1.46
Outcome after surgical treatment performed within the first week of antimicrobial therapy during infective endocarditis: a prospective study. Arch Cardiovasc Dis (2008) 1.44
Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Crit Care Med (2007) 1.43
Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trials. Biometrics (2009) 1.31
Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain (2007) 1.29
Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: results of a survey in 387 patients. J Hepatol (2011) 1.26
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer (2013) 1.24
Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J (2012) 1.23
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors. Neuro Oncol (2010) 1.22
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial. Target Oncol (2012) 1.13
Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact. Am J Trop Med Hyg (2012) 1.12
Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients. Cancer (2008) 1.12
Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med (2005) 1.11
The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J (2009) 1.09
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Qual Life Res (2008) 1.08
Experimenting with new paradigms for medical education and the emergence of a distance learning degree using the internet: teaching evidence-based medicine. Med Inform Internet Med (2002) 1.08
Prospective evaluation of nonenhanced MR imaging in acute pancreatitis. J Magn Reson Imaging (2007) 1.03
Novel virus influenza A (H1N1sw) in South-Eastern France, April-August 2009. PLoS One (2010) 1.02
Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed? Eur J Cancer (2012) 1.02
Treatment of classic Whipple's disease: from in vitro results to clinical outcome. J Antimicrob Chemother (2013) 1.01
Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. Neuro Oncol (2010) 1.01
Solitary fibrous tumors of the central nervous system: clinicopathological and therapeutic considerations of 18 cases. Neurosurgery (2007) 1.00
Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma. Radiother Oncol (2008) 0.98
Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol (2013) 0.98
Risk of reoperation for aortic bioprosthesis dysfunction. J Heart Valve Dis (2009) 0.98
A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians. Breast Cancer Res Treat (2013) 0.98
Tamoxifen therapy for patients with breast cancer. Lancet (2013) 0.97
Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis. Clin Infect Dis (2013) 0.96
Laparoscopy-assisted abdominal aortic aneurysm endoaneurysmorraphy: early and mid-term results. J Vasc Surg (2003) 0.95
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. J Hepatol (2012) 0.94
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting. J Hepatol (2010) 0.91
Development of anti-cancer drugs. Discov Med (2010) 0.90
Efficiency of new dose escalation designs in dose-finding phase I trials of molecularly targeted agents. PLoS One (2012) 0.90
Dose-finding design using mixed-effect proportional odds model for longitudinal graded toxicity data in phase I oncology clinical trials. Stat Med (2013) 0.90
Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents. Target Oncol (2010) 0.89
Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study. Europace (2012) 0.88
Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J (2012) 0.88
Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Acta Neurochir (Wien) (2009) 0.88
Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data. Malar J (2014) 0.87
Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma. Virchows Arch (2008) 0.87
Determinants of compliance with anti-vectorial protective measures among non-immune travellers during missions to tropical Africa. Malar J (2011) 0.87
Cervical paragangliomas: is SDH genetic analysis systematically required? Eur Arch Otorhinolaryngol (2007) 0.86
Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol (2007) 0.85
A platform to develop and to improve effectiveness of online computable guidelines. Stud Health Technol Inform (2003) 0.84
Flexible modeling of the effects of continuous prognostic factors in relative survival. Stat Med (2011) 0.84
Impaired smooth pursuit in schizophrenia results from prediction impairment only. Biol Psychiatry (2010) 0.84
A joint frailty model to estimate the recurrence process and the disease-specific mortality process without needing the cause of death. Stat Med (2014) 0.84
Tension-free vaginal tape and associated procedures: a case control study. Eur Urol (2004) 0.84
Analysis of swallowing after partial frontolateral laryngectomy with epiglottic reconstruction for glottic cancer. Eur Arch Otorhinolaryngol (2013) 0.84
Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes. Arch Cardiovasc Dis (2008) 0.83
Clinical outcome after repair of acute type A dissection in patients over 70 years-old. Eur J Cardiothorac Surg (2002) 0.83
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer. PLoS One (2012) 0.82
Links between private habits, psychological stress and brain cancer: a case-control pilot study in France. J Neurooncol (2010) 0.82
Flexible modeling of competing risks in survival analysis. Stat Med (2010) 0.82
Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope. Heart (2012) 0.82
Rebuttal to editorial saying cancer survival statistics are misleading. BMJ (2011) 0.82
Laparoscopy-assisted reconstruction to treat severe aortoiliac occlusive disease: early and midterm results. J Vasc Surg (2004) 0.82
Patterns of pain-free response in 497 cases of classic trigeminal neuralgia treated with Gamma Knife surgery and followed up for least 1 year. J Neurosurg (2012) 0.81
Quantification of myocardial blood flow and flow reserve in rats using arterial spin labeling MRI: comparison with a fluorescent microsphere technique. NMR Biomed (2011) 0.81
Slow dynamics of lymphoscintigraphic mapping is associated to the negativity of the sentinel node in melanoma patients. Ann Surg Oncol (2008) 0.81
Phase II study of XR5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with advanced ovarian cancer. Invest New Drugs (2003) 0.81
Secondary procedures after infrarenal abdominal aortic aneurysms endovascular repair with second-generation endografts. Ann Vasc Surg (2011) 0.81
High cell surface CD26-associated activities and low plasma adenosine concentration in fibromyalgia. Ann Rheum Dis (2012) 0.81
Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali. Malar J (2014) 0.81
Trends in excess mortality in follicular lymphoma at a population level. Eur J Haematol (2014) 0.80
Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. Eur Heart J (2009) 0.80
High endogenous adenosine plasma concentration is associated with atrial fibrillation during cardiac surgery with cardiopulmonary bypass. Int J Cardiol (2012) 0.80
A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stained. Virchows Arch (2014) 0.80
Ischemia-modified albumin and adenosine plasma concentrations are associated with severe systemic inflammatory response syndrome after cardiopulmonary bypass. J Crit Care (2013) 0.79
Dealing with missing data in the Center for Epidemiologic Studies Depression self-report scale: a study based on the French E3N cohort. BMC Med Res Methodol (2013) 0.79
Adenosine A2A receptor hyperexpression in patients with severe SIRS after cardiopulmonary bypass. J Investig Med (2008) 0.79
Semi-automated detection of the foveal avascular zone in fluorescein angiograms in diabetes mellitus. Clin Experiment Ophthalmol (2006) 0.79
Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty. Int J Cardiol (2011) 0.79
Immediate and medium-term results of intraoperative parathyroid hormone monitoring during video-assisted parathyroidectomy. Arch Surg (2004) 0.79
Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J Am Coll Cardiol (2009) 0.79
Operating characteristics of two independent sample design in phase I trials in paediatric oncology. Eur J Cancer (2010) 0.78
The Very Long-Term Outcome of Radiosurgery for Classical Trigeminal Neuralgia. Stereotact Funct Neurosurg (2016) 0.78
Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART). Drug Alcohol Depend (2008) 0.78
Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessment. J Clin Microbiol (2007) 0.78
Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation. Pharmacoepidemiol Drug Saf (2014) 0.77